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Kalrn promoter usage and isoform expression
respond to chronic cocaine exposure
Richard E Mains1*, Drew D Kiraly1, Jodi E Eipper-Mains2, Xin-Ming Ma1, Betty A Eipper1
Abstract
Background: The long-term effects of cocaine on behavior are accompanied by structural changes in excitatory
glutamatergic synapses onto the medium spiny neurons of the striatum. The Kalrn gene encodes several
functionally distinct isoforms; these multidomain guanine nucleotide exchange factors (GEFs) contain additional
domains known to interact with phosphatidylinositides as well as with a number of different proteins. Through
their activation of Rho proteins and their interactions with other proteins, the different Kalirin isoforms affect
cytoskeletal organization. Chronic exposure of adult male rodents to cocaine increases levels of Kalirin 7 in the
striatum. When exposed chronically to cocaine, mice lacking Kalirin 7, the major adult isoform, fail to show an
increase in dendritic spine density in the nucleus accumbens, show diminished place preference for cocaine, and
exhibit increased locomotor activity in response to cocaine.
Results: The use of alternate promoters and 3’-terminal exons of the mouse Kalrn gene were investigated using
real-time quantitative polymerase chain reaction. While the two most distal full-length Kalrn promoters are used
equally in the prefrontal cortex, the more proximal of these promoters accounts for most of the transcripts
expressed in the nucleus accumbens. The 3’-terminal exon unique to the Kalirin 7 isoform accounts for a greater
percentage of the Kalrn transcripts in prefrontal cortex than in nucleus accumbens. Western blot analyses
confirmed these differences. Chronic cocaine treatment increases usage of the promoter encoding the Δ-Kalirin
isoforms but does not alter full-length Kalirin promoter usage. Usage of the 3’-terminal exon unique to Kalirin 7
increases following chronic cocaine exposure.
Conclusions: Kalrn promoter and 3’-terminal exon utilization are region-specific. In the nucleus accumbens,
cocaine-mediated alterations in promoter usage and 3’-terminal exon usage favor expression of Kalirin 7 and
Δ-Kalirin 7. The Δ-isoform, which lacks a Sec14p domain and four of the nine spectrin-like repeats found in full-
length Kalirin isoforms, increases spine headsize without increasing dendritic spine numbers. Thus cocaine-
mediated changes in alternative splicing of the Kalrn gene may contribute importantly to the behavioral,
morphological and biochemical responses observed.
Background
Despite the expression of multiple Rho GDP/GTP
exchange factors (GEFs) in the nervous system, the Kalrn
gene, which encodes multiple isoforms of Kalirin, plays an
essential, non-redundant role. Linkage analyses identified
Kalrn as a major risk factor for coronary artery disease
and stroke [1-3], as well as for schizophrenia and adult
attention-deficit/hyperactivity disorder [4-6]. In addition,
Kalirin interacts with many different proteins including
deleted in schizophrenia 1 (DISC1), a major risk factor for
schizophrenia, the inducible form of nitric oxide synthase
(iNOS; NOS2), Huntingtin-associated protein 1 (HAP1)
and peptidylglycine a-amidating monooxygenase, an
essential enzyme for neuropeptide biosynthesis [7-11].
Chronic cocaine treatment increases levels of Kal7 protein
in the mouse and rat striatum [12]. Estrogen treatment of
ovariectomized female rats increases Kalirin expression
[13], and Alzheimer’s Disease is accompanied by a dra-
matic loss of Kal7 in the hippocampus [14]. Hippocampal
Kalirin mRNA is elevated at 4 h following a kainate-
induced seizure and remains elevated for a month [15].
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Kalirin has been implicated in many functions. Kalirin
is one of a small number of RhoGEFs localized to the
postsynaptic density (PSD) [16]. In the adult brain,
Kalirin 7 (Kal7) is the predominant isoform and is
almost exclusively localized to the PSD [17,18]. Overex-
pression of Kal7 leads to increases in dendritic spine
number in cultured hippocampal and cortical pyramidal
neurons [19-21]. Conversely, a specific reduction of Kal7
in primary neurons causes a dramatic decrease in spine
density [13,21]. Studies on Kalirin have focused on cor-
tex and hippocampus, where Kal7 has a clear role in
spine formation and maintenance.
With many functional domains, the different Kalirin
isoforms are capable of integrating inputs from a vari-
ety of surface molecules (ephrins, N-cadherin, Trk
receptors), phosphatidylinositides, cytoskeletal compo-
nents, PDZ domain proteins like spinophilin and PSD-
95, plus signaling molecules and growth factors
[18,22-25]. Kal7 is also crucial for the expression of
normal long-term potentiation in CA1 hippocampal
pyramidal neurons [17].
The rat Kalrn gene encompasses more than 65 exons
spanning 600 kb of the rat genome, with at least six
promoters and five 3’-terminal exons [26-28]. Alterna-
tive splicing yields multiple functionally different iso-
forms of rat Kalirin. We recently developed a mutant
mouse specifically lacking the Kal7 isoform (Kal7KO)
[17]; the 3’-terminal exon that encodes a PDZ binding
motif known to interact with PSD-95 and AF-6 was
eliminated [18,25]. Kal7KO mice show decreased anxi-
ety-like behavior, impaired acquisition of a passive
avoidance task, and abnormal behavioral and morpho-
logical responses to chronic cocaine [12,17]. A total
Kalirin knockout mouse (T-KalKO) mice, in which
exons 27-28 in the first GEF domain were replaced by
a neomycin resistance gene, was also developed [29].
T-KalKO mice also display a number of neurological
phenotypes. Use of these mouse models to clarify the
role of Kalirin proteins in synaptic plasticity requires
better characterization of the major products of the
mouse Kalrn gene.
Given the essential role of Kal7 in multiple cocaine-
elicited behaviors as well as the interactions of Kalirin
with cyclin dependent kinase 5 (Cdk5) and the NR2B
subunit of the NMDA receptor [12,17,18,30], proteins
important for these behaviors, we chose to examine
more closely the effects of cocaine on the expression
of different Kalirin isoforms in the striatum and,
more specifically, in the ventral striatum or nucleus
accumbens. In order to identify the striatal cell types
expressing Kal7, we took advantage of mice expres-
sing GFP under control of the D1-dopamine receptor
promoter.
Methods
Cocaine treatment of mice
Mice were kept in the University of Connecticut Health
Center animal facility on a 12 h light/dark cycle (lights
on 7:00 am to 7:00 pm) and handled in accordance with
University of Connecticut Health Center Institutional
Animal Care and Use Committee guidelines. Adult male
C57BL/6 mice (Jackson Laboratories; 2-5 months old)
were treated daily with cocaine (20 mg/kg/day, i.p.) or
saline for 7 days [12] and sacrificed 24 h after the final
injection. When tested, the mice exhibited the expected
locomotor sensitization to chronic cocaine administra-
tion (not shown) [12]. Mice expressing green fluorescent
protein (GFP) under the control of the D1-dopamine
receptor promoter were from the University of Missouri
Mutant Mouse Regional Resource Center (Tg(Drd1a-
EGFP)X60Gsat/Mmmh). These mice were bred at least
seven generations into C57Bl/6 (Jackson Labs) before use.
Quantitative polymerase chain reaction (Q-PCR)
RNA was prepared from freshly dissected tissues with
Trizol (Invitrogen) following the manufacturer’s instruc-
tions, except that the isopropanol precipitation step was
lengthened to overnight at -20°C and there were 2 etha-
nol washes instead of one. The cDNA samples were pre-
pared using Superscript II (Invitrogen) and random
primers, or iScript (BioRad) with random primers; a
5 min 65°C step was added to the iScript protocol
before chilling and adding the enzyme. While GAPDH
and actin samples were unaltered by the choice of ran-
dom priming or oligo-dT priming, Kalirin transcripts,
which are much longer, appeared to be 10-50-fold less
abundant compared to GAPDH when using oligo-dT
priming instead of random priming. Pairwise statistical
comparisons used the t-test for two samples assuming
unequal variance and the two-tailed value is reported.
Real-time PCR was performed using an Eppendorf
Realplex2 machine and Sybr-Green (BioRad), with the
default parameters (95°C 2 min; 95°C 15 sec, 55°C 15 sec,
68°C 20 sec; repeat 40x) except that the 68°C elongation
was lengthened to 40 sec. Maximal rates of amplification
per cycle were calculated for all primer pairs and all sam-
ples in all assays and averaged 1.98 ± 0.06 (SD) for a set
of 8 consecutive 96-well assays. Data are calculated with
respect to GAPDH for each sample within an assay; since
values with respect to GAPDH for each transcript were
consistent across assays, data were averaged. Use of actin
instead of GAPDH for normalization did not alter the
results. Primers are listed in Table 1.
All primer pairs were chosen to keep the melt tem-
perature (Tm) between 58 and 62°C (calculated using
http://www.basic.northwestern.edu/biotools/oligocalc.
html) and products in the 135 ± 20 nt size range.
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Primers were designed to delineate the unique 5’ end of
ΔKalirins (AF229255.1), the spectrin domains common
to all forms of Kalirin with nine spectrin-like repeats
(U88157.1), and sequences unique to the 3’ ends of Kal7
(AF230644.1), Kal8 (U88157.1), Kal9 (AF232668.1), and
Kal12 (NM_032062.2); rat sequences were used to iden-
tify the corresponding mouse sequences, which all
appear as Ensembl sequences at http://www.ensembl.
org/Mus_musculus/Info/. Additional primer pairs identi-
fying transcripts which extend beyond a unique end (e.g.
Exon 33 to Exon 34, Exon 38-39, Exon 51-52) instead of
terminating in a specific 3’ end, corroborated the major
findings (not shown).
Putative mouse Kalrn mRNA initiation exons A, B, C
and D were identified by homology to the rat and
human Kalrn initiation exons [27,28], as described here.
Mouse Kalrn exons A, B, and C were identified by com-
paring the known rat sequences (A: Genbank U88157.1;
B: U88156.1; C: AF230644.1) with the mouse genome
(July 2007 [NCBI37/mm9]) at http://genome.ucsc.edu/
cgi-bin/. The putative mouse Kalrn D initiation exon
sequence was from XM_001001454.1, and the putative
mouse ΔKalrn initiation exon sequence was from
ENSMUST00000114949. The A, B, and C sequences all
fit the current Ensembl sequences, and C is also a
Refseq entry: NM_177357.
Immunofluorescence analysis
Adult male Drd1a-GFP mice were anesthetized with
ketamine/xylazine and perfused transcardially with sal-
ine followed by 4% paraformaldehyde as described [13].
Brains from two mice were postfixed in 4% paraformal-
dehyde and then incubated in 25% sucrose in phosphate
buffered saline containing 0.02% NaN3. Coronal sections
(12 μm) through the striatum and nucleus accumbens
were collected on slides and incubated with rat mono-
clonal antibody to GFP (Nacalai USA, Elkton MD) and
affinity-purified rabbit polyclonal antibody to the
C-terminus of Kal7 [17,18]. Anatomical boundaries were
determined as in our previous studies using standard
atlases [31,32]. Confocal images were acquired on a
Zeiss LSM 510 microscope as described [13,21]. Neu-
rons expressing GFP and/or Kal7 were identified using
MetaMorph; three sections, each of which contained
~40 neurons, were analyzed from each animal for each
brain region. Since the minimum distance between sec-
tions analyzed using the same antiserum was 84 μm, the
same neuron was not counted twice.
Table 1 Primers used for quantitative polymerase chain reaction
Gene Name Oligo Name Sequence Tm (°C) Length (nt)
GAPDH mrGapdh-top TTGTCAGCAATGCATCCTGCACCACC 61 119
mrGapdh-rev2bot CTGAGTGGCAGTGATGGCATGGAC 61
3’-terminal exons
Kalirin7-specific KalEx33-for GATACCATATCCATTGCCTCCAGGACC 61 127
Kal7unique-rev CCAGGCTGCGCGCTAAACGTAAG 62
Kalirin8-specific KalEx38-for CTGACGTGCCTACTGCTGCAGAC 61 130
Kal8unique-rev CTGGTTGAGGTCCTGGGAGCCAC 62
Kalirin9-specific KalEx51-for GCCCCTCGCCAAAGCCACAGC 62 125
Kal9unique-rev CCAGTGAGTCCCGTGGTGGGC 62
Kalirin12-specific KalEx62-for CAGCAGCCACGTGCCTGCAGC 62 140
KalEx62-rev TCTTGACATTGGGAATGGGCCGCAC 61
Promoter-specific
Kalirin A promoter KalPromA-for CAGGGCAGCCATAAATGGTTTTATCTG 58 121
KalEx3-rev CCTCGCTTGTCACGCCCCC 60
Kalirin B promoter KalPromB-for GTGGACGCCTTTTTCCGGACAG 59 116
KalEx3-rev CCTCGCTTGTCACGCCCCC 60
Kalirin C promoter KalPromC-for CTTGCTTCGGCTTCTGGATCGAG 59 117
KalEx3-rev CCTCGCTTGTCACGCCCCC 60
Kalirin D promoter KalPromD-for CTTTGTTTCTTCCTCACTGCAGCGG 59 120
KalEx3-rev CCTCGCTTGTCACGCCCCC 60
ΔKalirin promoter ΔKalProm-for ATCCCAGGGTGAGCAGTGAGAAGG 61 144
mKal-Ex11-rev ATTCCCCAGTCTGAGCCAGCTGC 61
Full-length Kalirins mKal-Ex10-for GCCTTTCTCAGCAAACACACTGGGG 61 157
mKal-Ex11-rev ATTCCCCAGTCTGAGCCAGCTGC 61
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Subcellular fractionation and Western blot analysis
Adult male mouse nucleus accumbens, dorsal striatum
and cortical punches were sonicated and boiled in 1%
SDS, 50 mM Tris [pH 7.4], 5 mM EDTA, 50 mM NaF,
2 mM sodium orthovanadate, 1 mM PMSF and protease
inhibitor cocktail [17]. For subcellular fractionation stu-
dies, whole striatum was homogenized, fractionated by
differential centrifugation followed by sucrose gradient
centrifugation and extraction with TX-100, and sub-
jected to Western blot analysis. Where indicated, blots
were quantified using Gene Tools (Syngene, Frederick,
MD) [12,17,33]. Gels were loaded with equal protein
using a Bicinchoninic Acid Assay and bovine serum
albumin standard to determine protein concentrations
(Pierce, Rockford, IL). Commercially available mouse
monoclonal antibodies were used: bIII tubulin (TUJ1;
Covance), NR2B (clone N59/20; NeuroMab), Cdk5
(Santa Cruz Biotechnology) and Rac1 (Transduction
Labs; also 23A8, Millipore).
Results
Kal7 is expressed in the major neuronal cell types in
nucleus accumbens and dorsal striatum
Understanding the role Kal7 plays in the effects of
cocaine on locomotor activity and place preference
requires knowing the striatal cell types in which it is
expressed. Mice expressing GFP under the control of
the D1 dopamine receptor (Drd1a-GFP mice) were used
to investigate the cellular specificity of Kalirin expres-
sion in the dorsal striatum and nucleus accumbens
(Figure 1). In both regions, more than half of the neurons
express GFP, identifying them as D1 receptor positive
medium spiny neurons; this ratio is consistent with pub-
lished studies [34,35]. Over 90% of the D1 receptor neu-
rons express Kal7. About one-third of the neurons in
both regions express Kal7 but do not express GFP. D1
receptor negative neurons that are similar in size to the
D1 receptor positive neurons represent medium spiny
neurons expressing the D2 dopamine receptor [34,35].
The small population of very large neurons expressing
high levels of Kal7 are aspiny cholinergic interneurons
(Figure 1D-F) [36]. Kal7 could play a role at excitatory
synapses onto each of these different neuronal cell types.
Usage of promoters encoding full-length mouse Kalrn is
region-specific
With the generation of mice lacking the 3’-terminal
exon unique to Kal7 and ΔKal7 (Kal7KO mice) [17]
and the distinctly different response of Kal7KO mice to
chronic cocaine exposure [12], a detailed analysis of
Kalrn promoter usage and isoform expression in Mus
musculus was undertaken (Figure 2). The genes encod-
ing rat and human Kalrn are complex, with multiple
initiation exons and multiple 3 ’-terminal exons
responsible for the tissue-specific production of
transcripts encoding functionally distinct proteins
[26-28]. The gene encoding mouse Kalrn is similarly
large, extending over 600 kb (Figure 2). Expression of
full-length isoforms of Kalrn, in which a Sec14p
domain and nine spectrin-like repeats precede the first
GEF domain, is governed by four promoters and their
alternative initiation exons (B, C, A, and D) located
1.4 to 180 kb upstream of exon 2 [27,28] (Figure 2).
The alternative initiation exons, which are separated
by large introns, encode unique N-termini that are
five to 38 amino acids long. Exons 2 to 5 (35 kb)
encode the common Sec14p-like domain while exons
5 through 22 (150 kb) encode the nine spectrin-like
repeats. Exons 24 through 32 encode the first GEF
domain. The 3 ’-terminal exon unique to Kal7 and
ΔKal7 is flanked by two large introns while the exons
encoding the second GEF domain (exons 39-47),
which is present in Kal9 and Kal12, and the Ser/Thr
kinase domain (exons 58-60), which is unique to
Kal12, are densely clustered (Figure 2).
Full-length Kalirin promoter usage was assessed by
real-time Q-PCR; forward primers located in each initia-
tion exon were paired with a common reverse primer
located in exon 3 (Figure 3A). In addition to nucleus
accumbens, RNA from prefrontal cortex and hippocam-
pus was analyzed to look for region-specific promoter
usage. Although PCR products of the expected size were
detected for all four putative full-length promoters,
Kalrn promoters B and C accounted for over 95% of the
full-length Kalirin transcripts in the adult mouse brain
(Figure 3B); usage of promoters A and D was detectable
in all three brain regions, but was much less common.
The promoter usage patterns for hippocampus and
nucleus accumbens were similar to each other, but dif-
fered from the pattern observed in the prefrontal cortex.
Full-length Kalrn promoters B and C were used equally
in the prefrontal cortex, while promoter C was the
major promoter in the hippocampus and nucleus
accumbens.
Usage of ΔKalrn promoter and alternate 3’-terminal exons
is region-specific
In the adult rat brain, usage of a promoter located in
the intron that separates exons 10 and 11 yields the
Δ-isoforms of Kalirin (Figures 2 and 4A). These iso-
forms lack the Sec14p domain and the first four spec-
trin-like repeats of full-length Kalirin. In rat cortical and
hippocampal neurons, expression of exogenous Kal7
causes the formation of new dendritic spines. In con-
trast, expression of ΔKal7 increases spine size, but does
not increase spine number [24].
Expression of transcripts encoding full-length vs.
Δ-isoforms of Kalirin in mouse prefrontal cortex and
nucleus accumbens was compared using Q-PCR with
the indicated primers (Figure 4A); these regions were
Mains et al. BMC Neuroscience 2011, 12:20
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analyzed because both play essential roles in the
response to cocaine and their patterns of promoter
usage differed. Transcripts encoding the Δ-isoforms of
Kalirin were more prevalent in prefrontal cortex than in
nucleus accumbens (Figure 4B). Based on using primer
pairs that spanned exons 10 and 11 (Figure 4A), tran-
scripts encoding full-length isoforms of Kalirin were
expressed at similar levels in these two brain regions.
Primers specific to the 3’-terminal exons unique to the
different Kalrn isoforms (Figures 2, 4A) were used to
look for differences between prefrontal cortex and
nucleus accumbens (Figure 4C). Q-PCR analysis
revealed much higher levels of transcripts encoding the
Kal7-specific exon in prefrontal cortex than in nucleus
accumbens. These transcripts could encode full-length
Kal7 or ΔKal7. The Kal7-specific exon encodes a PDZ-
binding domain known to interact with PSD-95 and spi-
nophilin [18]. Transcripts encoding Kal8, Kal9 and
Kal12 were detected at much lower levels in both tis-
sues, with no tissue-specific differences. The isoforms of
Kalirin that include both GEF1 and GEF2 (Kal9, Kal12)
account for a larger fraction of the Kalirin transcripts in
the nucleus accumbens than in the prefrontal cortex.
Kal7 is the major Kalirin protein in the dorsal striatum and
nucleus accumbens
Western blot analysis was used to compare expression
of the major Kalirin isoforms in adult mouse cortex,
where its role in spine formation has been studied
[17,29,30,32,37-39] to dorsal striatum and nucleus
accumbens (ventral striatum), the brain regions affected
Figure 1 Kal7 is expressed in the major neuronal cell types in nucleus accumbens and striatum. Male Tg(Drd1a-EGFP)X60Gsat/Mmmh
mice were deeply anesthetized, fixed by perfusion with 4% paraformaldehyde, and brains were sectioned as described [17]. Sections were
stained for GFP (green) and Kal7 (red) and imaged with a confocal microscope. A-C. NAc core. D-F. Striatum. Scale bar, 20 μm. A collapsed
Z-stack (0.5 μm steps) is shown. A total 249 neurons in six sections from two mice (GFP+Kal7, Kal7 only and GFP only) were counted in the
striatum: 98% of the GFP-positive neurons contained Kal7 and 2% did not; 33% of the Kal7-positive neurons did not contain GFP. A total of 239
neurons in six sections from two mice were counted in the NAc: 92% of the GFP-positive neurons contained Kal7 and 8% did not; 31% of the
Kal7-positive neurons did not contain GFP.
Mains et al. BMC Neuroscience 2011, 12:20
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Figure 2 Structure of the mouse Kalrn gene and major transcripts. Genomic and transcript information was compiled from websites
(http://www.ensembl.org/Mus_musculus/Info/; http://genome.ucsc.edu/cgi-bin/) and our previous work [26-28] to create an accurate map of the
mouse Kalrn gene and the major brain transcripts, as described in Methods. Protein domains (http://smart.embl-heidelberg.de/) encoded by
groups of exons are indicated.
Figure 3 Full-length Kalirin promoter usage varies in different brain regions. A. Putative promoter regions (red line) and initiation exons in
the mouse Kalrn gene, which is located on mouse chromosome 16, were identified based on homology to human and rat Kalrn [27,28];
translational start sites are indicated by bent arrows. The introns separating promoters B, C, A and D, which produce full-length Kalirin, are not
drawn to scale. The location of each initiation exon is indicated by the nucleotide number below the line; the location of the initiation exon-
specific forward primers is indicated, along with the common reverse primer in Exon 3. B. RNA prepared from adult mouse prefrontal cortex
(PFC), hippocampus (Hippo) and nucleus accumbens (NAc) was subjected to Q-PCR analysis using these primers; data were normalized to
GAPDH. The same data are plotted on a log scale to allow visualization of data for full-length Kalirin promoters A and D, and as a percentage of
the total in each brain region.
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most dramatically by cocaine [12,35,40-47]. Using an
antibody specific for spectrin repeats 4-7 of Kalirin
(Kal-Spec Ab), cross-reactive proteins the size of Kal12
(337 kDa), Kal9 (271 kDa), Kal7 (190 kDa) and ΔKal7
(117 kDa) were detected (Figure 5, top left). Higher
levels of Kal12, Kal7 and ΔKal7 were present in cortex
than in dorsal or ventral striatum. In contrast, levels of
bIII tubulin were similar in all three brain regions.
To confirm the identity of the bands identified as Kal7
and ΔKal7, antiserum specific to the unique COOH-
terminus of Kal7 was used (Figure 5, top right). Levels of
both Kal7 and ΔKal7 were higher in cortex than in striatum
or nucleus accumbens, with a clear signal for ΔKal7
detected only in cortex. As observed in the rat [26,28], levels
of ΔKal7 protein were significantly lower than predicted
based on utilization of the ΔKalrn promoter (Figure 4B).
Kalirin function is altered when Thr1590 is phosphory-
lated by cyclin dependent kinase 5 (Cdk5), and levels of
both Cdk5 and NR2B are decreased in PSDs prepared
from Kal7KO animals [17,30]. We therefore compared
levels of NR2B and Cdk5 in these three brain regions
(Figure 5); similar levels of both proteins were detected
in all three regions. We also examined levels of Rac1, one
of the major substrates of Kal7, in the same brain regions;
again, no dramatic differences were observed (Figure 5).
Striatal PSDs are enriched in Kal7
In the rat, mouse and gerbil cortex and hippocampus,
subcellular fractionation reveals a significant enrichment
Figure 4 Expression of transcripts encoding different Kalirin isoforms varies in nucleus accumbens and prefrontal cortex. A. The
proteins encoded by the major isoforms of rat and human Kalirin are drawn to scale; although Δ-isoforms of Kal8, -9 and -12 have been
identified [26-28], only ΔKal7 is depicted. The ΔKal isoforms are produced when the ΔKal promoter is used instead of the A, B, C, or D promoters
diagramed in Figure 2. The sense and anti-sense primers used for real-time Q-PCR are shown in red; 5’- and 3’-untranslated regions of the
corresponding transcripts are indicated by red lines. The Kal7-specific and Kal-spectrin antibody epitopes are indicated by blue lines. B. RNA
prepared from mouse nucleus accumbens (NAc) and prefrontal cortex (PFC) was subjected to real-time Q-PCR analysis using the ΔKal and full-
length primers; three separate preparations of RNA from each tissue were analyzed in triplicate and data were normalized to GAPDH. C. PFC and
NAc expression of Kalirin isoforms was examined via Q-PCR analysis of 3’-terminal exons encoding Kal7, Kal8, Kal9 and Kal12. Higher levels of
Kal7 transcript were seen in the PFC than the NAc.
Mains et al. BMC Neuroscience 2011, 12:20
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of Kal7 at the PSD [3,17,18]. We prepared PSDs from
mouse striatum to examine the distribution of the dif-
ferent Kalirin isoforms in this brain region (Figure 6).
The distributions of BiP, an ER resident chaperone, and
the NR2B subunit of the NMDA receptor, were used to
verify the success of the fractionation scheme. As
expected, BiP was enriched in the P3 fraction, which
contains ER, Golgi and other intracellular membranous
compartments, and NR2B was enriched in the PSD frac-
tion. Cytosol was enriched in Kal12 and Kal9 and was
devoid of Kal7. Kal7 was enriched in the PSD fraction,
which also contained detectable amounts of Kal12 and
Kal9, but no detectable ΔKal7.
Since Rac1 is one of the key substrates of Kal7, its dis-
tribution was also monitored (Figure 6). Although
attached to the membrane by a geranylgeranyl tail, most
of the Rac1 remained associated with the TX-100
washed PSD fraction. Very little Rac1 was removed by
the TX-100 extraction step, leaving the TX-100 soluble
fraction (TxS) depleted of Rac1.
We previously quantified the amount of Kal7 in puri-
fied PSDs prepared from adult mouse hippocampus and
cortex [17]. Using purified ΔKal7 as a standard, the
same measurement was made on purified striatal PSDs
(Figure 7). The levels of Kal7 in striatal-PSDs were
about half of those observed in the cortex and hippo-
campus. A difference of this magnitude is consistent
with the results of in situ hybridization studies of Kalirin
expression in these tissues [32].
Chronic cocaine treatment alters promoter and
3’-terminal exon expression
Adult male mice were treated with cocaine (20 mg/kg)
for 7 days and nucleus accumbens was then harvested for
preparation of RNA (Figure 8). Utilization of full-length
Kalrn promoters A, B, C and D was first evaluated; fol-
lowing injection of saline or cocaine, Kalrn promoter C
accounted for most of the full-length transcripts pro-
duced (Figure 8A). Usage of the ΔKalrn promoter was
next compared to the total level of full-length Kalrn tran-
script (Figure 8B). Chronic cocaine treatment increased
usage of the ΔKalrn promoter without altering expres-
sion of full-length transcripts (Figure 8B).
The effect of chronic cocaine on usage of different
Kalrn 3’-terminal exons was next evaluated (Figure 8C).
In the nucleus accumbens, the number of Kalirin tran-
scripts generated using the Kal7-specific 3’-terminal
exon increased following chronic treatment with
cocaine. No significant change was seen in the level of
transcripts encoding Kal8 or Kal12 and levels of Kal9
fell slightly (Figure 8C).
Effect of chronic cocaine on expression of Kalirin isoforms
in striatal neurons
In order to evaluate changes in Kalirin isoform expres-
sion, PSDs were prepared from the striata of mice trea-
ted chronically with saline or cocaine (Figure 9A).
Analysis of equal amounts of input (S1) and PSD pro-
tein revealed increased levels of Kal7 protein in both
samples. DARPP32, a soluble protein enriched in striatal
Figure 5 Kalirin is not as highly expressed in the striatum as in
the cortex. A. Tissue taken from the cortex (Ctx), dorsal striatum (Str)
and nucleus accumbens (NAc) of adult C57BL/6 mice was disrupted
by sonication in SDS lysis buffer; aliquots containing equal amounts
of protein (20 μg) were fractionated by SDS-PAGE and visualized
using antibody to the spectrin repeat region of Kalirin or to Kal7 and
the indicated proteins: bIII tubulin, NR2B, Cdk5 and Rac1.
Figure 6 Kal7 and Rac1 are enriched in mouse striatal PSDs.
Adult mouse striatum homogenized in buffer containing 0.32 M
sucrose was subjected to differential centrifugation as described in
Methods. After hypotonic lysis, synaptosomal membranes were
pelleted, resuspended and subjected to equilibrium sucrose density
centrifugation. Fractions were collected from the top (Sample) to
bottom [Pellet (mitos)] of the gradient; the fraction taken from the
interface of the 1.0/1.2 M sucrose layers was extracted with TX-100,
yielding a TX-soluble fraction (TxS) and the PSD fraction. Equal
amounts of protein (5 μg) from each fraction were subjected to
SDS-PAGE; Kalirin was visualized using the Kal-spectrin antibody and
the Kal7 antibody. The NR2B subunit of the NMDA receptor served
as a PSD marker; BiP served as an endoplasmic reticulum marker.
Rac1, one of the substrates of Kal-GEF1, was also localized to PSDs.
Cyt = cytosol; ER/G = endoplasmic reticulum/Golgi-enriched
fraction.
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neurons, was excluded from the purified PSDs, attesting
to their purity. Small amounts of Kal9 and Kal12 could
be detected in the purified PSDs, but Kal12 was barely
detectable in the input samples. The identification of
the Kal7 band was verified with the Kal7-specific anti-
body (Figure 9B).
Many of the effects of cocaine involve the nucleus
accumbens, or ventral striatum. Since preparation of
purified PSDs from this relatively small region would
require the use of multiple animals, we evaluated the
effects of chronic cocaine on total lysates. Western blot
analyses of nucleus accumbens extracts with the
Kal-spectrin antibody revealed a 60% increase in Kal7
protein levels (Figure 9C); Kal9 levels were unchanged
following cocaine treatment and Kal12 levels were too
low for accurate quantification.
Discussion and Conclusions
Tissue-specific use of full-length Kalrn Promoters
The pattern of Kalrn promoter usage differs in NAc and
prefrontal cortex; the C-promoter accounts for most of
the full-length transcripts in the NAc while the B- and
C-promoters contribute equally in the prefrontal cortex.
The rat Kalrn A promoter was the first one identified
and came from a cDNA library prepared from P21 rat
hippocampus and cortex following electroconvulsive
shock [11]. Subsequent studies demonstrated that the
Kalrn A promoter is a minor contributor in the adult
rat, mouse and human tissues examined [27,28]. The
Kalrn D promoter is also a minor contributor in adult
brain, but is the dominant Kalrn promoter in the pitui-
tary (not shown). The Duet promoter, which produces
transcripts that lack all of Kal7, is rarely used in the rat
or human brain [28] and was not examined in this
study. Interestingly, the intron sizes shown for mouse in
Figure 1 are virtually identical to those reported for rat
and human [28].
The N-terminal sequences encoded by the mouse and
rat Kalrn B promoters are identical, as are the
N-terminal sequences encoded by the mouse and rat
Kalrn C promoters. Most of the full-length Kalirin iso-
forms in the NAc will begin with the more hydrophobic
N-terminal sequence encoded by the Kalrn C promoter
[48]. The functional consequences of this difference
have not yet been explored, but the proximity of this
short sequence to the Sec14p domain, which is known
to bind phosphatidylinositol-3-phosphate [24], suggests
that future studies might identify an important role for
the N-terminus of Kalirin.
Figure 7 Striatal PSDs contain less Kalirin than cortical or
hippocampal PSDs. TX-100 extracted PSDs were prepared from
adult mouse cortex, hippocampus and striatum as described above.
A. The indicated amount of protein was subjected to SDS-PAGE and
Kal7 was visualized using the Kal7-specific antibody. B. Known
amounts of purified ΔKal7 were analyzed at the same time, making
it possible to calculate fmol Kal7/μg PSD protein using Gene Tools;
data for two different amounts of protein were averaged; error bars
show the range. The cortex and hippocampus numerical data in B
are repeated from [17] for comparison.
Figure 8 Chronic exposure to cocaine increases usage of the
ΔKal promoter and the Kal7 3’-terminal exon. Samples of RNA
were prepared from the nucleus accumbens of three sets of mice
treated with cocaine (20 mg/kg for 7 days) or saline. A. Promoter
usage was evaluated using the primers described in Figure 1.
Cocaine treatment had no effect on usage of full-length Kalrn
promoters A, B, C, or D. B. Chronic cocaine treatment increased
usage of the ΔKal promoter. C. Usage of the different Kalirin 3’-
terminal exons was evaluated as described in Figures 2-3; usage of
the Kal7-specific 3’-terminal exon increased following chronic
cocaine treatment.
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Cocaine regulation of ΔKalrn promoter and Kal7
3’-terminal exon usage
Chronic cocaine treatment increased the prevalence of
transcripts generated using the ΔKalrn promoter (Figure
8B). Neither the level of full-length Kalirin transcripts
nor usage of the Kalrn B and C promoters (Figure 8A)
was altered by this treatment. Chronic cocaine treat-
ment is known to increase expression of several tran-
scription factors, including CREB, ΔFosB, MEF2 and
Sp1, in the NAc [45,47,49-51]. Our own analyses
demonstrated an increase in transcripts encoding CREB,
MEF2 and Sp1 in the NAc of mice treated with this par-
ticular regimen of cocaine [52].
We therefore examined 1 kilobase of genomic sequence
immediately upstream of the ΔKal, Kal B and Kal C tran-
scriptional start sites for the presence of consensus bind-
ing sites for these four transcription factors (Figure 10).
Consensus sites for CREB, ΔFosB and MEF2A were not
found in these regions. A consensus Sp1 site (GGGCGG)
was identified close to the ΔKalrn transcriptional start
site [53]; this site is perfectly conserved in mouse and rat.
Consensus Sp1 sites, or close matches, were identified in
the Kalrn B, Kalrn C and Kalrn A promoters, but are
over 300 nucleotides from the transcriptional start site;
none occur in the Kalrn D promoter (Figure 10). Because
they are GC-rich, Sp1 sites are strongly affected by chro-
matin methylation [54]. Interfering pharmacologically
with Sp1 function (e.g. with mithramycin) is known to
block psychostimulant sensitization [51] and Sp1 binding
to the proximal promoters of the mu opioid receptor has
been clearly demonstrated [55].
Chronic treatment with cocaine also increased the level
of transcripts that include the Kal7-specific 3’-terminal
exon (Figure 8). Inclusion of this 3’-terminal exon results
in the production of transcripts encoding Kal7 or ΔKal7
and precludes the production of Kal8, Kal9 or Kal12.
Since chronic cocaine treatment had no effect on the
level of full-length Kalirin transcripts (Figure 8B), an
increase in the splicing events that include the
Kal7-specific 3’-terminal exon would be associated with
diminished usage of other 3’-terminal exons. While usage
of the Kal8- and Kal12-specific exons was unaltered, usage
of the Kal9-specific 3’-terminal exon declined slightly.
The effects of cocaine treatment on alternative spli-
cing have received little attention. However, acute expo-
sure to cocaine is known to alter splicing of transcripts
encoded by the rat BDNF gene [56]. BDNF, acting
through its TrkB receptor, plays an important role in
the behavioral response to cocaine and enhances
responsiveness to glutamate [57-59]. Cocaine- and activ-
ity-regulated alternative splicing of the Homer family of
scaffolding proteins also affects synaptic signaling
[43,60]. For Kalrn, splicing events that lead to the inclu-
sion of different 3’-terminal exons produce proteins
with distinctly different functions. Since the GEF2
region of Kalirin can be activated upon binding Gaq
[61], leading to activation of RhoA, even a slight shift in
the ratio of isoforms with both GEF domains vs GEF1
alone should be of significance. Cocaine-induced alter-
native splicing of Kalrn transcripts may be important in
the biochemical and/or behavioral response to cocaine.
Kalirin expression in the striatum
The primary site of action of cocaine is the nucleus
accumbens and the rest of the striatum [47,62,63]. Kal7
Figure 9 Effect of chronic exposure to cocaine on expression
of Kalirin protein. A. Striata harvested from Saline and Cocaine
treated mice were subjected to subcellular fractionation; equal
amounts (10 μg) of input (S1) and PSD were fractionated by
SDS-PAGE. Kalirin proteins were visualized using the Kal-spectrin
antibody. DARPP32, a soluble protein highly expressed in the
striatum, was excluded from the PSD fraction. B. Striata prepared
in a similar fraction to A show increases in Kal7 in the S1 and PSD
fractions while demonstrating a lack of Kal7 in the Triton soluble
fraction as was expected from previous results [17,18]. C. Levels of
Kal7 and Kal9 in SDS lysates prepared from the nucleus
accumbens of chronically Saline and Cocaine treated mice were
compared to levels of bIII-tubulin; Kal12 levels were not high
enough to allow accurate quantification. The Kalirin/Tubulin ratios
for Kal7 and Kal9 were calculated for Saline and Cocaine treated
mice, with the Saline ratio normalized to 100%; using an unpaired
t-Test, Kal7 expression (p < 0.05) differed significantly while Kal9
expression did not.
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is expressed in almost all of the neurons in the dorsal
striatum and nucleus accumbens that express the D1
receptor, but its expression is not limited to this popula-
tion of neurons. Since medium spiny neurons expressing
the D1 dopamine receptor and the D2 dopamine recep-
tor receive different excitatory glutamatergic inputs and
are part of very different functional pathways [34],
examining the role of Kal7 in the effects of cocaine on
both neuronal populations will be important. Whether
expression of high levels of Kal7 in giant aspiny striatal
cholinergic interneurons [36,63] plays an important role
in the actions of cocaine will require additional studies.
Based on Q-PCR analysis, expression of Kalirin in the
NAc is lower than in hippocampus or prefrontal cortex.
Consistent with a role for Kalirin in spine formation,
dendritic spine density on NAc medium spiny neurons
is lower than on hippocampal CA1 pyramidal neurons
[12,24]. In addition, PSDs purified from mouse striatum
contained substantially lower levels of Kal7 than PSDs
from cortex or hippocampus (Figure 7A). While the
typical cortical or hippocampal PSD is estimated to have
9-12 molecules of Kal7, the typical striatal PSD would
have only five.
Western blot analysis revealed an increase in levels of
Kal7 in lysates of NAc and in purified striatal PSDs fol-
lowing chronic cocaine treatment (Figure 9). Many fac-
tors contribute to steady state protein levels, but the
cocaine-stimulated increase in usage of the Kal7-specific
3’-terminal exon, coupled with maintained usage of the
full-length Kalrn C promoter could account for the
observed change. No cocaine-mediated alteration in
Kal9 protein levels was observed (Figure 9B), despite a
decrease in usage of the Kal9 specific 3’-terminal exon
(Figure 8C). While ΔKal7 is detectable in mouse cortex,
it is far less prevalent than predicted by promoter usage.
The presence of four start codons followed by in-frame
Figure 10 Potential Sp1 sites in proximal regions of ΔKal, KalB and KalC promoters. The 1 kilobase of genomic sequence 5’ to the Δ, KalB
and KalC transcriptional start sites was analyzed using Transcription Factor Search (http://www.cbrc.jp/research/db/TFSEARCH.html); mouse ΔKal
(ENSMUST00000114949), rat ΔKal (AF229255.1), human ΔKal (BM920956.1; NM_001024660.2 starts 291 nt further 3’), mouse KalB (U88156.1) and
mouse KalC (AF230644.1; NM_177357). The Sp1 consensus site definition is from [53]. Only one human cDNA corresponding to the mouse and
rat ΔKal transcripts was identified; the 5’ extent of the human transcript may be longer than depicted here, making the distance from the Sp1
site to the start of transcription shorter.
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stop codons in the 5’-untranslated region of mouse
ΔKal7 may limit successful translation [64], and
increased turnover ΔKal7, a soluble, cytosolic protein,
may contribute to this discrepancy.
A transient, cocaine-mediated change in levels of Kal7
vs. ΔKal7 would be expected to have functional signifi-
cance. While expression of exogenous Kal7 increases
spine density in cortical and hippocampal pyramidal
neurons and even in interneurons [13,21,24], expression
of exogenous ΔKal7 does not. Expression of ΔKal7 does
increase spine head size [24] and the cocaine-mediated
increase in ΔKalrn promoter usage may contribute to
the increase in spine width known to occur following
cocaine administration [12,24]. Kal7 binding to its part-
ners might be disrupted by ΔKal7, much as Homer-1a
disrupts the clusters of proteins formed with the longer
constitutive splice variants of the Homer family [60].
Initial studies on Kal7KO mice confirmed a role for
Kal7/ΔKal7 in nervous system function [12,17]. A slight
decrease in linear spine density on CA1 hippocampal
pyramidal neurons is accompanied by a decrease in
spontaneous EPSP frequency and deficient hippocampal
LTP [17]. In contrast, spine density is normal in the
Kal7KO NAc under basal conditions [12]. Although
chronic administration of cocaine increases spine den-
sity on the medium spiny neurons in the NAc
[35,42,65], this response is absent in Kal7KO mice [12].
The behavioral responses of Kal7KO mice to chronic
cocaine are also altered [12]. Levels of both Cdk5 and
NR2B, which play essential roles in the structural and
behavioral responses to cocaine [17,30,41,66-69], are
diminished in PSDs prepared from the cortices of
Kal7KO mice. A similar relationship between Kal7 and
Cdk5 and NR2B in the NAc may contribute to the
behavioral deficits observed.
Although the Na+-dependent plasma membrane
dopamine transporter is the immediate target of
cocaine, the effects of chronic exposure to cocaine are
complex, wide-spread and long-lasting. Since no effec-
tive treatment is available, it is essential to develop a
better understanding of the molecular, cellular and sys-
tem-wide changes that lead to addiction. Structural
changes at many of the synapses involved in addiction
are thought to underlie these long-lived changes. Since
dendritic spine morphology is largely controlled by the
actin cytoskeleton, attention has turned to the path-
ways through which cocaine could alter the cytoskele-
ton. Small GTP binding proteins of the Rho family
play an important role in this process and are activated
by RhoGEFs and inactivated by Rho GTPase Activating
Proteins. There are ~60 RhoGEFs in the human gen-
ome, and about a dozen are found in significant
amounts at the PSD [16]. We have focused on one of
these RhoGEFs, Kalirin, because it is essential for
normal synaptic function and mice engineered to lack
its major adult isoform exhibit altered responses to
cocaine [12,17].
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